Publications by Schoenermarck, Ulf

Journal article

Gaeckler, Anja; Schoenermarck, Ulf; Dobronravov, Vladimir; La Manna, Gaetano; Denker, Andrew; Liu, Peng; Vinogradova, Maria; Yoon, Sung-Soo; Praga, Manuel (2021): Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis. In: BMC Nephrology, Vol. 22, No. 1, 5

Kronbichler, Andreas; Geetha, Duvuru; Smith, Rona M.; Egan, Allyson C.; Bajema, Ingeborg M.; Schoenermarck, Ulf; Mahr, Alfred; Anders, Hans-Joachim; Bruchfeld, Annette; Cid, Maria C.; Jayne, David R. W. (2021): The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum. In: Autoimmunity Reviews, Vol. 20, No. 12, 102986

Schoenermarck, Ulf; Ries, Wolfgang; Schroeppel, Bernd; Pape, Lars; Dunaj-Kazmierowska, Malgorzata; Burst, Volker; Mitzner, Steffen; Basara, Nadezda; Starck, Michael; Schmidbauer, Daniel; Mellmann, Alexander; Dittmer, Rita; Jeglitsch, Michael; Haas, Christian S. (2020): Relative incidence of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in clinically suspected cases of thrombotic microangiopathy. In: Clinical Kidney Journal, Vol. 13, No. 2: pp. 208-216

Voelker, Linus A.; Kaufeld, Jessica; Miesbach, Wolfgang; Braehler, Sebastian; Reinhardt, Martin; Kuehne, Lucas; Muehlfeld, Anja; Schreiber, Adrian; Gaedeke, Jens; Toelle, Markus; Jabs, Wolfram J.; Oezcan, Fedai; Markau, Silke; Girndt, Matthias; Bauer, Frederic; Westhoff, Timm H.; Felten, Helmut; Hausberg, Martin; Brand, Marcus; Gerth, Jens; Bieringer, Markus; Bommer, Martin; Zschiedrich, Stefan; Schneider, Johanna; Elitok, Saban; Gawlik, Alexander; Gaeckler, Anja; Kribben, Andreas; Schwenger, Vedat; Schoenermarck, Ulf; Roeder, Maximilian; Radermacher, Jörg; Bramstedt, Joern; Morgner, Anke; Herbst, Regina; Harth, Ana; Potthoff, Sebastian A.; Auer, Charis von; Wendt, Ralph; Christ, Hildegard; Brinkkoetter, Paul T.; Menne, Jan (2020): Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. In: Blood Advances, Vol. 4, No. 13: pp. 3085-3092

Voelker, Linus A.; Kaufeld, Jessica; Miesbach, Wolfgang; Braehler, Sebastian; Reinhardt, Martin; Kuehne, Lucas; Muehlfeld, Anja; Schreiber, Adrian; Gaedeke, Jens; Toelle, Markus; Jabs, Wolfram J.; Ozcan, Fedai; Markau, Silke; Girndt, Matthias; Bauer, Frederic; Westhoff, Timm H.; Felten, Helmut; Hausberg, Martin; Brand, Marcus; Gerth, Jens; Bieringer, Markus; Bommer, Martin; Zschiedrich, Stefan; Schneider, Johanna; Elitok, Saban; Gawlik, Alexander; Gaeckler, Anja; Kribben, Andreas; Schwenger, Vedat; Schoenermarck, Ulf; Roeder, Maximilian; Radermacher, Jörg; Bramstedt, Joern; Morgner, Anke; Herbst, Regina; Harth, Ana; Potthoff, Sebastian A.; Auer, Charis von; Wendt, Ralph; Christ, Hildegard; Brinkkoetter, Paul T.; Menne, Jan (2020): ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP. In: Blood Advances, Vol. 4, No. 13: pp. 3093-3101

Grigorescu, Melissa; Kamla, Christine-Elena; Wassilowsky, Dietmar; Joskowiak, Dominik; Peterss, Sven; Kemmner, Stephan; Pichlmaier, Maximilian; Hagl, Christian; Fischereder, Michael; Schoenermarck, Ulf (2020): Severe Acute Kidney Injury in Cardiovascular Surgery: Thrombotic Microangiopathy as a Differential Diagnosis to Ischemia Reperfusion Injury. A Retrospective Study. In: Journal of Clinical Medicine, Vol. 9, No. 9, 2900

Kauke, Teresa; Oberhauser, Cornelia; Lin, Viviane; Coenen, Michaela; Fischereder, Michael; Dick, Andrea; Schoenermarck, Ulf; Guba, Markus; Andrassy, Joachim; Werner, Jens; Meiser, Bruno; Angele, Martin; Stangl, Manfred; Habicht, Antje (2017): De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability. In: Transplant international, Vol. 30, No. 4: pp. 360-370

Kauke, Teresa; Klimaschewski, Sandra; Schoenermarck, Ulf; Fischereder, Michael; Dick, Andrea; Guba, Markus; Stangl, Manfred; Werner, Jens; Meiser, Bruno; Habicht, Antje (2016): Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
In: PLOS ONE 11(1), e0146075 [PDF, 461kB]

Fischereder, Michael; Schoenermarck, Ulf (2016): Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes: Letter to the edditor. In: New England Journal of Medicine, Vol. 374, No. 11: pp. 1092-1093

Schnitzler, Fabian; Friedrich, Matthias; Stallhofer, Johannes; Schoenermarck, Ulf; Fischereder, Michael; Habicht, Antje; Karbalai, Nazanin; Wolf, Christiane; Angelberger, Marianne; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Goeke, Burkhard; Zachoval, Reinhart; Denk, Gerald; Guba, Markus; Rust, Christian; Gruener, Norbert; Brand, Stephan (2015): Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.
In: PLOS ONE 10(8), e0135807 [PDF, 545kB]

Rau, Simon; Wessely, Matthias; Lange, Philipp; Kupatt, Christian; Steinbeck, Gerhard; Fischereder, Michael; Schoenermarck, Ulf (2012): Transcatheter Aortic Valve Implantation in Dialysis Patients. In: Nephron Clinical Practice, No. 2: C86-C90 [PDF, 163kB]

Durner, Juergen; Winkler-Budenhofer, Ursula; Gahr, Simon; Samtleben, Walter; Schoenermarck, Ulf (2011): Pseudohypocalcemia caused by perchlorate (Irenat (R)). In: Clinical Chemistry and Laboratory Medicine, Vol. 49, No. 4: pp. 665-667 [PDF, 72kB]